PlexPCR® SARS-CoV-2 is a dual-target, single-well, multiplex reverse transcriptase qPCR test for the detection of COVID-19 causing coronavirus (SARS-CoV-2) plus RNA internal control. The PlexPCR® SARS-CoV-2 is designed for laboratories.
Scalable solution supporting surge capacity
Clinically relevant turnaround times
- Nasopharyngeal swabs and aspirates, nasal swabs and throat swabs
The PlexPCR® SARS-CoV-2 is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy PlexPCR® SARS-CoV-2 for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the PlexPCR® SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the PlexPCR® SARS-CoV-2 or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.